| Popis: |
Abstract Background In Iran, the delay in diagnosis and treatment of breast cancer results in low survival rates. Aim It is essential to characterize new therapeutic targets and prognostic breast cancer biomarkers. The rising evidence suggested that long non‐coding RNAs (lncRNAs) expression levels are deregulated in human cancers and can use as biomarkers for the rapid diagnosis of breast cancer. Methods In the present study, a quantitative real‐time polymerase chain reaction (qRT‐PCR) technique was used to measure 20 oncogenic and tumor suppressor lncRNAs expression levels in whole blood samples of female breast cancer patients and healthy women. Receiver operating characteristic curve (ROC) was used to assess the diagnostic value of each selected lncRNA as a biomarker. Results The results revealed that some circulating lncRNAs (MEG3, NBAT1, NKILA, GAS5, EPB41L4A‐AS2, Z38, and BC040587) were significantly down‐regulated in breast cancer patients compared to healthy women. In contrast, other circulating lncRNAs (H19, SPRY4‐IT1, XIST, UCA1, AC026904.1, CCAT1, CCAT2, ITGB2‐AS, and AK058003) were significantly up‐regulated in breast cancer patients compared to controls. It was shown that the expression levels of NKILA, and NBAT1 lncRNAs were related to tumor size, and BC040587 expression level related to age, node metastasis, tumor size, and grade (p |
Plný text